Eintrag weiter verarbeiten
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168: P2.168
Gespeichert in:
| Zeitschriftentitel: | Journal of Hypertension |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Journal of Hypertension, 18, 2000, S. S132 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Ovid Technologies (Wolters Kluwer Health)
|
| Schlagwörter: |
| author_facet |
Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. |
|---|---|
| author |
Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. |
| spellingShingle |
Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. Journal of Hypertension CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 Cardiology and Cardiovascular Medicine Physiology Internal Medicine |
| author_sort |
park, j. k. |
| spelling |
Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. 0263-6352 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology Internal Medicine http://dx.doi.org/10.1097/00004872-200006001-00459 P2.168 CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 Journal of Hypertension |
| doi_str_mv |
10.1097/00004872-200006001-00459 |
| facet_avail |
Online |
| finc_class_facet |
Biologie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwNDg3Mi0yMDAwMDYwMDEtMDA0NTk |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwNDg3Mi0yMDAwMDYwMDEtMDA0NTk |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
| imprint |
Ovid Technologies (Wolters Kluwer Health), 2000 |
| imprint_str_mv |
Ovid Technologies (Wolters Kluwer Health), 2000 |
| issn |
0263-6352 |
| issn_str_mv |
0263-6352 |
| language |
English |
| mega_collection |
Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| match_str |
park2000cerivastatininhibitsinflammatorymechanismsandamelioratesendorgandamageviainhibitionofthemapkinasepathwayandnfkbactivationp2168p2168 |
| publishDateSort |
2000 |
| publisher |
Ovid Technologies (Wolters Kluwer Health) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Hypertension |
| source_id |
49 |
| title_sub |
P2.168 |
| title |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_unstemmed |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_full |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_fullStr |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_full_unstemmed |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_short |
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_sort |
cerivastatin inhibits inflammatory mechanisms and ameliorates end-organ damage via inhibition of the map kinase pathway and nfkb activation : p2.168 |
| topic |
Cardiology and Cardiovascular Medicine Physiology Internal Medicine |
| url |
http://dx.doi.org/10.1097/00004872-200006001-00459 |
| publishDate |
2000 |
| physical |
S132 |
| description |
|
| container_start_page |
0 |
| container_title |
Journal of Hypertension |
| container_volume |
18 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792323667685802000 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:37:28.272Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=CERIVASTATIN+INHIBITS+INFLAMMATORY+MECHANISMS+AND+AMELIORATES+END-ORGAN+DAMAGE+VIA+INHIBITION+OF+THE+MAP+KINASE+PATHWAY+AND+NFkB+ACTIVATION+%3A+P2.168&rft.date=2000-06-01&genre=article&issn=0263-6352&volume=18&pages=S132&jtitle=Journal+of+Hypertension&atitle=CERIVASTATIN+INHIBITS+INFLAMMATORY+MECHANISMS+AND+AMELIORATES+END-ORGAN+DAMAGE+VIA+INHIBITION+OF+THE+MAP+KINASE+PATHWAY+AND+NFkB+ACTIVATION+%3A+P2.168&aulast=Haller&aufirst=H.&rft_id=info%3Adoi%2F10.1097%2F00004872-200006001-00459&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792323667685802000 |
| author | Park, J. K., Muller, D. N., Mervaala, E. M.A., Schmidt, F., Bieringer, M., Schunck, W.-H., Ganten, D., Luft, F. C., Haller, H. |
| author_facet | Park, J. K., Muller, D. N., Mervaala, E. M.A., Schmidt, F., Bieringer, M., Schunck, W.-H., Ganten, D., Luft, F. C., Haller, H., Park, J. K., Muller, D. N., Mervaala, E. M.A., Schmidt, F., Bieringer, M., Schunck, W.-H., Ganten, D., Luft, F. C., Haller, H. |
| author_sort | park, j. k. |
| container_start_page | 0 |
| container_title | Journal of Hypertension |
| container_volume | 18 |
| description | |
| doi_str_mv | 10.1097/00004872-200006001-00459 |
| facet_avail | Online |
| finc_class_facet | Biologie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwNDg3Mi0yMDAwMDYwMDEtMDA0NTk |
| imprint | Ovid Technologies (Wolters Kluwer Health), 2000 |
| imprint_str_mv | Ovid Technologies (Wolters Kluwer Health), 2000 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
| issn | 0263-6352 |
| issn_str_mv | 0263-6352 |
| language | English |
| last_indexed | 2024-03-01T11:37:28.272Z |
| match_str | park2000cerivastatininhibitsinflammatorymechanismsandamelioratesendorgandamageviainhibitionofthemapkinasepathwayandnfkbactivationp2168p2168 |
| mega_collection | Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| physical | S132 |
| publishDate | 2000 |
| publishDateSort | 2000 |
| publisher | Ovid Technologies (Wolters Kluwer Health) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Hypertension |
| source_id | 49 |
| spelling | Park, J. K. Muller, D. N. Mervaala, E. M.A. Schmidt, F. Bieringer, M. Schunck, W.-H. Ganten, D. Luft, F. C. Haller, H. 0263-6352 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology Internal Medicine http://dx.doi.org/10.1097/00004872-200006001-00459 P2.168 CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 Journal of Hypertension |
| spellingShingle | Park, J. K., Muller, D. N., Mervaala, E. M.A., Schmidt, F., Bieringer, M., Schunck, W.-H., Ganten, D., Luft, F. C., Haller, H., Journal of Hypertension, CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168, Cardiology and Cardiovascular Medicine, Physiology, Internal Medicine |
| title | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_full | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_fullStr | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_full_unstemmed | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_short | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| title_sort | cerivastatin inhibits inflammatory mechanisms and ameliorates end-organ damage via inhibition of the map kinase pathway and nfkb activation : p2.168 |
| title_sub | P2.168 |
| title_unstemmed | CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168 |
| topic | Cardiology and Cardiovascular Medicine, Physiology, Internal Medicine |
| url | http://dx.doi.org/10.1097/00004872-200006001-00459 |